US Patent Issued to Regeneron Pharmaceuticals, California Institute of Technology on Feb. 10 for "IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making" (California Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,546,785, issued on Feb. 10, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.) and California Institute of Technology (Pasadena, Calif.).

"IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making" was invented by Heather Agnew (Culver City, Calif.), Bert Tsunyin Lai (Culver City, Calif.), Suresh Mark Pitram (La Jolla, Calif.), Blake Farrow (Pasadena, Calif.), James R. Heath (South Pasadena, Calif.), David Bunck (Pasadena, Calif.), Jingxin Liang (Pasadena, Calif.), Arundhati Nag (Pasadena, Calif.) and Samir Das (Pasadena, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides s...